Ticker
  • Annals of Time (5-1) gets clear late in the Grade 1 Hollywood Derby.Posted 23 hours ago
  • Vale Dori (1-2) much the best in the Grade 2 Bayakoa.Posted 23 hours ago
  • Royal Posse (3-5) repeats in the Claiming Crown Jewel and becomes a millionaire.Posted 1 day ago
  • King and His Court (8-5) flies home to win the Display Stakes.Posted 1 day ago
  • R Angel Katelyn (8-5) leads all the way in the Sandpiper.Posted 1 day ago
  • Rapid Rhythm runs them down in the Battle of New Orleans.Posted 1 day ago
  • Highway Star (7-1) is up in time to win the Go for Wand.Posted 1 day ago
  • Chance of Luck (7-2) holds on to take the Inaugural StakesPosted 1 day ago
  • Whitmore wins the 6th race at Aqueduct, his first race back since the Kentucky Derby.Posted 1 day ago
  • Even Thunder (5-2) holds on to win the King's Swan.Posted 2 days ago

Gulfstream Backs Off Lasix Ban

Gulfstream Park owner Frank Stronach’s desire to outlaw the raceday use of Lasix will not go into effect during the upcoming meeting, track president Tim Ritvo said on Wednesday.

Stronach sent a letter to state regulators last month asking for their help to implement a program that would ultimately phase out all raceday medications at the track, including the elimination of Lasix at its 2011-2012 meet, which begins Dec. 3. But after conferring Tuesday in Tallahassee with members of the Florida Department of Business and Professional Regulations, which oversees all parimutuel racing in Florida, Ritvo said the state is not yet ready to make such a commitment.

“Our company’s position is to phase out raceday medications,” said Ritvo. “Frank’s beliefs are basically the same as those being echoed recently by the Jockey Club, Breeders’ Cup and Graded Stakes Committee. We asked the state to help us implement this program in the best interests of racing and they said they’d be willing to take up the matter at a later date following an open forum on the subject.”

Ritvo said he offered to hold that forum at Gulfstream Park during the upcoming meet.
Read More

 

comments powered by Disqus

Related Pages

Related Stories

Top Stories